uniQure N.V. (NASDAQ: QURE)
$6.0100
+0.2300 ( +2.39% ) 233.7K
uniQure NV is a gene therapy company. It develops treatments and platforms for patients suffering from genetic and other devastating diseases. Its products and services are focused on hemophilia, Huntington's disease, and cardiovascular diseases. The company is focused on the development of the pipeline of gene therapies with the collaboration of Bristol Myers Squibb for cardiovascular diseases.
Market Data
Open
$6.0100
Previous close
$5.7800
Volume
233.7K
Market cap
$301.72M
Day range
$5.7800 - $6.2350
52 week range
$3.7300 - $11.3500
SEC Filings
Form Type | Description | Pages | Date |
---|---|---|---|
8-k | 8K-related | 15 | Nov 21, 2024 |
10-q | Quarterly Reports | 70 | Nov 05, 2024 |
8-k | 8K-related | 15 | Nov 05, 2024 |
8-k | 8K-related | 15 | Oct 15, 2024 |
8-k | 8K-related | 15 | Sep 23, 2024 |
8-k | 8K-related | 15 | Aug 15, 2024 |
8-k | 8K-related | 15 | Aug 01, 2024 |
10-q | Quarterly Reports | 72 | Aug 01, 2024 |
8-k | 8K-related | 15 | Jul 23, 2024 |
8-k | 8K-related | 15 | Jul 09, 2024 |